Case Comprehensive Cancer Center: Glioblastoma trials
The registry lists 16 Glioblastoma studies with Case Comprehensive Cancer Center as lead sponsor. 2 are open to participants now and 3 have results posted.
Early Phase 1 2Phase 1 6Phase 2 7No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 GliomasRecruitingNCT07003542Phase 2
- Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of ProgressionRecruitingNCT05565118Phase 1
- NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent GlioblastomaCompletedNCT01894061Phase 2Results posted
- Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade GliomaTerminatedNCT01095094Phase 2Results posted
- Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma MultiformeCompletedNCT00253448Phase 2Results posted
- Magnetic Resonance Fingerprinting Guided Extended Resection in GlioblastomasWithdrawnNCT06455189Phase 1
- Glioblastoma Remote Monitoring and Care - Research ProtocolSuspendedNCT06129760Not applicable
- Methimazole in Patients With Progressive GlioblastomaSuspendedNCT05607407Phase 2
- Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain TissueActive, not recruitingNCT04545177Not applicable
- Regorafenib in Bevacizumab Refractory Recurrent GlioblastomaCompletedNCT04051606Phase 2
- Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed GlioblastomaCompletedNCT03535350Phase 1
- Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and GlioblastomaCompletedNCT03514069Phase 1
- Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)CompletedNCT03277638Phase 1/2
- Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent GlioblastomaCompletedNCT02768389Early Phase 1
- Capecitabine + Bevacizumab in Patients With Recurrent GlioblastomaCompletedNCT02669173Phase 1
- Radiosurgery Plus Bevacizumab in GlioblastomaTerminatedNCT01086345Early Phase 1